	The Role of Extracellular Vesicles in the Treatment of Prostate Cancer. Small Hu C, Chen Q, Wu T, Du X, Dong Y, Peng Z, Xue W, Sunkara V, Cho YK, Dong L. PMID: 38639331 [PubMed - as supplied by publisher]
	Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients. Ther Adv Urol Buti S, Olivari A, Masini C, Bimbatti D, Sartori D, Ermacora P, Cattrini C, Vitale MG, Rossi E, Mucciarini C, Rizzo M, Sisani M, Santoni M, Roviello G, Mollica V, Conteduca V, Grillone F, Cinausero M, Prati G, Atzori F, Stellato M, Massari F, Bersanelli M. PMID: 38638242 [PubMed]
	Advancements in fertility preservation strategies for pediatric male cancer patients: a review of cryopreservation and transplantation of immature testicular tissue. Reprod Biol Endocrinol Sung ZY, Liao YQ, Hou JH, Lai HH, Weng SM, Jao HW, Lu BJ, Chen CH. PMID: 38637872 [PubMed - in process]
	Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI. NPJ Digit Med Kwong JCC, Wu J, Malik S, Khondker A, Gupta N, Bodnariuc N, Narayana K, Malik M, van der Kwast TH, Johnson AEW, Zlotta AR, Kulkarni GS. PMID: 38637674 [PubMed]
	RECIP 1.0 Predicts Progression-Free Survival After [(177)Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer. J Nucl Med Gafita A, Djaileb L, Rauscher I, Fendler WP, Hadaschik B, Rowe SP, Herrmann K, Solnes LB, Calais J, Rettig MB, Weber M, Farolfi A, Benz MR, Eiber M. PMID: 38637143 [PubMed - as supplied by publisher]
	Dietary Fiber Intake and Risk of Advanced and Aggressive Forms of Prostate Cancer: A Pooled Analysis of 15 Prospective Cohort Studies. J Acad Nutr Diet Sidahmed E, Freedland SJ, Wang M, Wu K, Albanes D, Barnett M, van den Brandt PA, Cook MB, Giles GG, Giovannucci E, Haiman CA, Larsson SC, Key TJ, Loftfield E, Männistö S, McCullough ML, Milne RL, Neuhouser ML, Platz EA, Perez-Cornago A, Sawada N, Schenk JM, Sinha R, Tsugane S, Visvanathan K, Wang Y, White KK, Willett WC, Wolk A, Ziegler RG, Genkinger JM, Smith-Warner SA. PMID: 38636793 [PubMed - as supplied by publisher]
	Measurement of glomerular filtration rate in patients undergoing renal surgery for cancer: eGFR vs mGFR in the era of precision medicine. Kidney Blood Press Res Trevisani F, Simeoni M, Bettiga A, Cinque A, Floris M. PMID: 38636485 [PubMed - as supplied by publisher]
	Disitamab Vedotin Alone or in Combination With Immune Checkpoint Inhibitors in Bladder-Sparing Treatment of Muscle-Invasive Bladder Cancer: A Real-World Study. Clin Genitourin Cancer Wang A, Chen M, Li D, Shi J, Tang W, Zhang Z, Ren S. PMID: 38636170 [PubMed - as supplied by publisher]
	PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer. Cancer Res Cunningham M, Schiewer MJ. PMID: 38635890 [PubMed - as supplied by publisher]
	Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. JAMA Oncol Tosoian JJ, Zhang Y, Xiao L, Xie C, Samora NL, Niknafs YS, Chopra Z, Siddiqui J, Zheng H, Herron G, Vaishampayan N, Robinson HS, Arivoli K, Trock BJ, Ross AE, Morgan TM, Palapattu GS, Salami SS, Kunju LP, Tomlins SA, Sokoll LJ, Chan DW, Srivastava S, Feng Z, Sanda MG, Zheng Y, Wei JT, Chinnaiyan AM, EDRN-PCA3 Study Group. PMID: 38635241 [PubMed - as supplied by publisher]
	Global real-world experiences with pembrolizumabÂ in advancedÂ urothelialÂ carcinoma after platinum-based chemotherapy: the ARON-2 study. Cancer Immunol Immunother Massari F, Santoni M, Takeshita H, Okada Y, Tapia JC, Basso U, Maruzzo M, Scagliarini S, Büttner T, Fornarini G, Myint ZW, Galli L, Souza VC, Pichler R, De Giorgi U, Gandur N, Lam ET, Gilbert D, Popovic L, Grande E, Mammone G, Berardi R, Crabb SJ, Kemp R, Molina-Cerrillo J, Freitas M, Luz M, Iacovelli R, Calabrò F, Tural D, Atzori F, Küronya Z, Chiari R, Campos S, Caffo O, Fay AP, Kucharz J, Zucali PA, Rinck JA, Zeppellini A, Bastos DA, Aurilio G, Mota A, Trindade K, Ortega C, Sade JP, Rizzo M, Fiala O, Vau N, Giannatempo P, Barillas A, Monteiro FSM, Dauster B, Mennitto A, Nogueira L, de Carvalho Fernandes R, Seront E, Aceituno LG, Grillone F, Cutuli HJ, Fernandez M, Bassanelli M, Kopp RM, Roviello G, Abahssain H, Procopio G, Milella M, Kopecky J, Martignetti A, Messina C, Caitano M, Inman E, Kanesvaran R, Herchhorn D, Santini D, Bamias A, Bisonni R, Mosca A, Morelli F, Maluf F, Soares A, Nunes F, Pinto A, Zgura A, Incorvaia L, Ansari J, Zabalza IO, Landmesser J, Rizzo A, Mollica V, Marchetti A, Rosellini M, Sorgentoni G, Battelli N, Buti S, Porta C, Bellmunt J. PMID: 38634928 [PubMed - indexed for MEDLINE]
	Radiomics and machine learning for renal tumor subtype assessment using multiphase computed tomography in a multicenter setting. Eur Radiol Uhlig A, Uhlig J, Leha A, Biggemann L, Bachanek S, Stöckle M, Reichert M, Lotz J, Zeuschner P, Maßmann A. PMID: 38634876 [PubMed - as supplied by publisher]
	Radical nephrectomy for a giant chromophobe renal cell carcinoma diagnosed > 17 years previously: a case report and literature review. Front Oncol Lan J, Lan D, Yuan W, Ying Q, He J, Gu Y. PMID: 38634044 [PubMed]
	Patient-centred pathology reporting improves patient experience and understanding of disease in prostate cancer care. BJUI Compass Al Saffar H, Thomson A, Tan JS, Wang Q, Birch E, Koschel S, Medhurst E, Jobson D, Ong S, Moon DA, Murphy D, Lawrentschuk N. PMID: 38633832 [PubMed]
	The impact of pre-biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review. BJUI Compass Tesfai A, Norori N, Harding TA, Wong YH, Hobbs MD. PMID: 38633829 [PubMed]
	Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer. BJUI Compass Al-Zubaidi M, Ong K, Viswambaram P, Bangash H, Boardman G, McCombie SP, Oey O, Swarbrick N, Redfern A, Ong J, Gauci R, Low R, Hayne D. PMID: 38633828 [PubMed]
	The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care. BJUI Compass Sindhu KK, Dovey Z, Thompson M, Nehlsen AD, Skalina KA, Malachowska B, Hasan S, Guha C, Tang J, Salgado LR. PMID: 38633827 [PubMed]
	The epidemiology of cryptorchidism and potential risk factors, including endocrine disrupting chemicals. Front Endocrinol (Lausanne) Holmboe SA, Beck AL, Andersson AM, Main KM, Jørgensen N, Skakkebæk NE, Priskorn L. PMID: 38633762 [PubMed - indexed for MEDLINE]
	An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study. J Transl Med Cheng Y, Wu L, Xin J, Ben S, Chen S, Li H, Zhao L, Wang M, Cheng G, Du M. PMID: 38632662 [PubMed - indexed for MEDLINE]
	Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model. J Transl Med Zheng K, Hai Y, Chen H, Zhang Y, Hu X, Ni K. PMID: 38632658 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 160796

Page 1 of 8040



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy